Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 studyArmando Santoro, Camillo Porta, Stefania Salvagni et al.|The Lancet Oncology|2012Cited by 550
Pain outcomes in patients with advanced breast cancer and bone metastasesCharles S. Cleeland, Karen Chung, Jean‐Jacques Body et al.|Cancer|2012Cited by 155